But the patients Fishman has treated at HUP during the last two weeks have had more severe symptoms than he usually sees this time of year.
Normally, as the winter flu season ends and officials track precipitous downward trends in reported cases of influenza A, there is an accompanying increase in influenza B cases, Fishman said.
For some reason, however, influenza A lingered longer than usual, and influenza B arrived slightly later than expected, he said.
Although they cannot be certain, Fishman said, epidemiologists have speculated that these shifts may be due to the particularly cold weather this winter, which allowed the virus to survive longer, or the fact that most of the influenza A was the H1N1 virus, which tends to be a more long-lived illness.
Flu data for the week ended March 22 show that 60 percent of samples tested were positive for influenza A and nearly 40 percent for influenza B.
In mid-February, influenza B was detected in less than 10 percent of samples.
Fortunately, the vaccines given last year accurately targeted most of the strains of flu, Fishman said. There are two influenza B strains, however, and the less common of them, he noted, was not covered by the vaccine that most people received.
Only people inoculated with the more expensive quadrivalent vaccine or those younger than 50 who were given the inhaled form would have been specifically protected against both types of influenza B.
It will be small comfort to those who have fallen victim already, Fishman said, but the spring flu usually does not afflict as many people, and its reign of terror does not last nearly as long as its winter cousin's.
"Influenza B is usually here and gone in six weeks," he said. "So we're hoping we'll start to see a downturn soon."